-
公开(公告)号:EP0591534B1
公开(公告)日:1996-11-06
申请号:EP92911803.2
申请日:1992-06-12
发明人: NAKAJIMA, Hidenori , HORI, Yasuhiro , GOTO, Toshio , TAKASE, Shigehiro , VERHAEGHE, Koen , TERANO, Hiroshi , OKUHARA, Masakuni
摘要: Substances WB2663A, WB2663B and WB2663C are produced by culturing a WB2663-producing bacterium belonging to the genus Pseudomonas to form physiologically active substances and isolating therefrom neutral substances respectively having the following specific rotation: [ alpha ] = -36 DEG (C =0.5 in CH2Cl2),[ alpha ] = -12 DEG (C =0.5 in CH2Cl2), and [ alpha ] = -9 DEG (C =0.5 in CH2Cl2). They have each an excellent antitumor activity.
-
公开(公告)号:EP0629184A1
公开(公告)日:1994-12-21
申请号:EP93905607.0
申请日:1993-03-03
发明人: GOTO, Toshio , SHIBATA, Toshihiro , OKUHARA, Masakuni , SAKAMOTO, Kazutoshi , HATANAKA, Hiroshi , TAKASE, Shigehiro , SATO, Tomoko
CPC分类号: C07C69/732 , C07C59/54 , C07D309/30 , C12P7/42 , C12P17/06 , C12P17/12
摘要: L'invention porte sur de nouveaux dérivés de tétraline ayant une activité inhibitrice contre la réductase de 3-hydroxy-3-méthylglutaryl-coenzyme A, représentés par la formule générale (I) dans laquelle R1 est hydrogène ou acétyle, R2 est carboxy et R3 est hydroxy, ou R2 et R3 peuvent former un lactone, et sels acceptables sur le plan pharmaceutique. L'invention se rapporte également à des procédés de production de ces composés, ainsi qu'à une composition pharmaceutique en renfermant.
-
公开(公告)号:EP0591534A1
公开(公告)日:1994-04-13
申请号:EP92911803.2
申请日:1992-06-12
发明人: NAKAJIMA, Hidenori , HORI, Yasuhiro , GOTO, Toshio , TAKASE, Shigehiro , VERHAEGHE, Koen , TERANO, Hiroshi , OKUHARA, Masakuni
摘要: Substances WB2663A, WB2663B and WB2663C are produced by culturing a WB2663-producing bacterium belonging to the genus Pseudomonas to form physiologically active substances and isolating therefrom neutral substances respectively having the following specific rotation: [α]²³ = -36° (C =0.5 in CH₂Cl₂),[α]²³ = -12° (C =0.5 in CH₂Cl₂), and [α]²³ = -9° (C =0.5 in CH₂Cl₂). They have each an excellent antitumor activity.
摘要翻译: 物质WB2663A,WB2663B和WB2663C通过培养属于假单胞菌属的产WB2663的细菌以形成生理活性物质并从中分离出分别具有如下比旋光度的中性物质:[α] 23 = -36°(C = 0.5英寸 CH 2 Cl 2),[α] 23 = -12°(CH 2 Cl 2中C = 0.5)和[α] 23 = -9°(CH 2 Cl 2中C = 0.5)。 他们每个人都有出色的抗肿瘤活性。
-
-